SYK - SYK ストライカ― （）

Allied Market Research Analyst have added a new research study on Title Emergency Stretcher Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Ferno, Byron Group Holdings, ZhangJiaGang RongChang Machinery Manufacture Co. Ltd., Hebei Pukang

Stryker saw volume-driven top-line growth because of meaningful acquisition. Read more to see what makes SYK stock unattractive.

Although the Federal Reserve remained the main topic of conversation on Wall Street, earnings news provided another major catalyst in Wednesday''s midday trading

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Rapid7, Inc. (NASDAQ: RPD ) climbed 23.2% to $49.13. Rapid7 is working with Goldman Sachs Group to explore a potential sale, Reuters reported. Peloton Interactive, Inc. (NASDAQ: PTON ) jumped 21% to $15.58 after the company reported better-than-expected Q2 sales results and issued guidance. MicroVision, Inc. (NASDAQ: MVIS ) climbed 16.3% to $2.9187. Mercury Systems, Inc. (NASDAQ: MRCY ) surged 16.2% to $58.08 following Q2 results. Silicon Laboratories Inc. (NASDAQ: Full story available on Benzinga.com

https://www.investing.com/news/pro/stryker-pt-raised-to-280-at-stifel-432SI-2993217

Stryker Corporation (NYSE:SYK) marked $205.48 per share on Thursday, down from a previous closing price of $205.82. While Stryker Corporation has underperformed by -0.17%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SYK fell by -23.30%, with highs and lows ranging from $280.43 to $188.84, whereas […]

Stryker (NYSE: SYK ) has outperformed the market over the past 15 years by 1.36% on an annualized basis producing an average annual return of 7.12%. Currently, Stryker has a market capitalization of $77.63 billion. Buying $1000 In SYK: If an … Full story available on Benzinga.com

NEW YORK , Sept. 28, 2022 /PRNewswire/ -- The Insight Partners published latest research study on " Orthopedic Implants Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, End User, and Geography", the global orthopedic implants market size is expected to grow from $46.10 Billion in 2021 to $67.23 Billion by 2028; it is expected to grow at a CAGR of 5.6% from 2022 to 2028. Download Sample Brochure of Orthopedic Implants Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00024316/ Orthopedic Implants Market Report Scope, Segmentations, Regional & Country Scope: Report Coverage Details Market Size Value in US$ 46.10 Billion in 2021 Market Size Value by US$ 67.23 Billion by 2028 Growth rate CAGR of 5.6% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021 No. of Pages 150 Historical data available Yes Segments covered Product, Application, End User, and Geography Regional scope North America; Europe; Asia Pacific; Latin America; MEA Country scope US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends Companies Covered DJO Finance LLC; Johnson & Johnson (DePuy Synthes); Medtronic Plc; Zimmer Biomet Holdings, Inc.; Stryker Corporation; NuVasive, Inc.; CONMED Corporation; Smith and Nephew Plc; Arthrex, Inc.; Globus Medical, Inc.

General Dynamics Corporation with ticker code (GD) now have 16 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 314 and 212 with a mean TP of 264.38. Given that the stocks previous close was at 220.43 this is indicating there is a potential upside of 19.9%. There is a 50 day moving average of 228.48 and the 200 day moving average is 224.55. The company has a market cap of $59,969m. You can visit the company''s website by visiting: https://www.gd.com [stock_market_widget type="chart" template="basic" color="green" assets="GD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $71,926m based on the market concensus. General Dynamics Corporation operates as an aerospace and defense company worldwide. It operates through four segments: Aerospace, Marine Systems, Combat Systems, and Technologies. The Aerospace segment designs, manufactures, and sells business jets; and offers aircraft maintenance and repair, management, charter, aircraft-on-ground support and completion, staffing, and fixed-base operator services.

The High Intensity Focused Ultrasound Devices market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The High Intensity Focused Ultrasound Devices report also incorporates the current and future global market outlook

Stryker Corporation with ticker code (SYK) now have 23 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 310 and 260 calculating the average target price we see 284.74. Given that the stocks previous close was at 241.36 this is indicating there is a potential upside of 18.0%. There is a 50 day moving average of 259.27 and the 200 moving average now moves to 262.38. The market cap for the company is $90,787m. You can visit the company''s website by visiting: https://www.stryker.com [stock_market_widget type="chart" template="basic" color="green" assets="SYK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $107,105m based on the market concensus. Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries.

Someone with a lot of money to spend has taken a bullish stance on Stryker (NYSE: SYK ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don''t know. But when something this big happens with SYK, it often means somebody knows something is about to happen. Today, Benzinga''s options scanner spotted 10 options trades for Stryker. This isn''t normal. The overall sentiment of these big-money traders is split between 60% bullish and 40%, bearish. Out of all of the options we uncovered, 9 are puts, for a total amount of $474,454, and there was 1 call, for a total amount of $37,440. What''s The Price Target? Taking into account the Volume and … Full story available on Benzinga.com

New York, USA, May 05, 2022 (GLOBE NEWSWIRE) -- The Global Orthopedic Trauma Devices Market is Anticipated to Surge at a CAGR of 6.41% Reaching USD 10.08 Billion by 2026, Analyzes DelveInsight The Orthopedic Trauma Devices market is expected to boost owing to the rising incidence of trauma and accident cases, the increasing prevalence of degenerative bone disorders, the increasing number of sports-related injuries, rising technological advancements pertaining to orthopedic trauma devices, and the rising number of new product launches, among others. According to the latest report published by DelveInsight, " Orthopedic Trauma Devices Market Insight Report ," the global Orthopedic Trauma Devices market is expected to witness significant growth owing to an increase in the prevalence of simple fractures and severe life-threatening injuries. Furthermore, the rising number of accidents or other fatal incidences, along with the rising number of trauma associated with road accidents, fall injuries, and the increasing prevalence pertaining to osteoarthritis and orthopedic sports injury, is also a major factor contributing to the growth of Orthopedic Trauma Devices market.

Stryker Corporation (NYSE: SYK ) reported 1Q FY22 results that beat on the top and bottom line, reflecting a solid rebound in procedure volumes in March. SYK expects FY22 organic revenue growth in its 6-8% range. SYK called out the supply chain and inflation issues and expected EPS to come near the low-end of its $9.60-10.00 range. RBC Capital Market remains on the sidelines at this time and maintains a Sector Perform rating. SYK reported Q1 sales of $4.3 billion , +8.1% Y/Y (+9.2% organic), … Full story available on Benzinga.com

Stryker Corp (NYSE:NYSE:SYK) Q1 2022 Earnings Conference Call April 28, 2022, 16:30 ET Company Participants Kevin Lobo - Chairman, CEO & President Preston Wells - VP, IR Glenn Boehnlein…